Skip to main navigation Skip to search Skip to main content

A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

  • Marvin E. Reid
  • , Amal El Beshlawy
  • , Adlette Inati
  • , Abdullah Kutlar
  • , Miguel R. Abboud
  • , Johnson Haynes
  • , Richard Ward
  • , Bruce Sharon
  • , Ali T. Taher
  • , Wally Smith
  • , Deepa Manwani
  • , Richard G. Ghalie

Research output: Contribution to journal › Article › peer-review

55   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science